Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

4.060 +0.090 (+2.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharma

< Previous 1 2 3 4 5 6 7 8 9 Next >
Inovio, Advaccine to Share $100M in Cost for Late-Stage COVID-19 Vaccine Trial
Inovio Pharmaceuticals Inc (NASDAQ: INO) has expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global... 
Via Benzinga
Exposures COVID-19
These Vaccine Latecomers Could Still Win Big. Here's How
The key is standing out from the crowd. 
Via The Motley Fool
Topics Cannabis
Exposures COVID-19 Cannabis
Why Inovio Pharmaceuticals Stock Perked Up in May
The biotech's pan-COVID-19 vaccine caught the eye of investors last month. 
Via The Motley Fool
Exposures COVID-19
I Would Hope Inovio Isn’t Attracting ANY Serious Money
It seems as though INO stock will have a tough time getting and staying in double digits 
Via InvestorPlace
Is It Too Late to Buy Inovio Pharmaceuticals Stock?
This troubled coronavirus vaccine developer has created far more woes than joys for investors. 
Via The Motley Fool
Exposures COVID-19
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... 
Via Talk Markets
Ocugen vs. Inovio: Where Is the Smart Money Going?
They're both seeking share in the vaccine market. 
Via The Motley Fool
Exposures COVID-19
Inovio's Latest COVID Vaccine Results: Too Little, Too Late?
Maybe not -- especially outside of the U.S. 
Via The Motley Fool
Exposures COVID-19
2 Things That May Boost This Beaten-Down Vaccine Stock
This company could benefit from a near-term need -- and a long-term one, as well. 
Via The Motley Fool
High Flyers At Much Lower Altitudes
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd. 
Via Talk Markets
1 Coronavirus Vaccine Company to Avoid Like The Plague in May (and Beyond)
This biotech's prospects look dim. 
Via The Motley Fool
Exposures COVID-19
Inovio's Pan-COVID-19 Vaccine Candidate Can Provide Immune Responses Against Variants, Animal Study Shows
Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced results from a preclinical study of its next-generation Pan-COVID-19 vaccine candidate, INO-4802, that... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints
Vaccine stocks crumbled Tuesday after Novavax announced a delay and Inovio's Covid vaccine disappointed in testing. Both NVAX stock and INO stock plunged. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Cerecor (NASDAQ:CERC) shares rose 14.56% to $2.91 during Tuesday's pre-market session. The company's market cap stands at $281.4 million. Larimar... 
Via Benzinga
Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript
INO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Inovio Pharmaceuticals Q1 Earnings
Shares of Inovio Pharmaceuticals (NASDAQ:INO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.85% over... 
Via Benzinga
Inovio's DNA COVID-19 Vaccine Candidate Triggers Immune Response In Pivotal Study
Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced positive data from the Phase 2 segment of its Phase 2/3 INNOVATE trial in the U.S.,... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
Exposures COVID-19 Product Safety
20 Stocks Moving in Monday's Pre-Market Session
Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer. SemiLEDs Corporation (... 
Via Benzinga
Preview: Inovio Pharmaceuticals's Earnings
Inovio Pharmaceuticals (NASDAQ:INO) announces its next round of earnings this Monday, May 10. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday morning, 58 companies hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was Lufax Holding (NYSE:LU).... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Cramer Weighs In On Coinbase, Kellogg And More
Jim Cramer said on CNBC's "Mad Money Lightning Round" that he has always felt that Ocugen Inc (NASDAQ: OCGN) is a great spec, but it's a heavily shorted stock... 
Via Benzinga
Can Inovio Recover From Its Huge Setback?
It might be able to, although it won't be easy. 
Via The Motley Fool
Exposures COVID-19
Is There Any Hope for Inovio?
Everything may depend on an early-stage program. 
Via The Motley Fool
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.